Drug Type Therapeutic vaccine |
Synonyms artLCMV TRP2, artLCMVTRP2 |
Target |
Mechanism TYRP2 inhibitors(dopachrome tautomerase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | 07 Feb 2024 | |
Melanoma | Preclinical | CH | 07 Feb 2024 |